$0.00010
Comments
Loading...
Molecular Pharmacology Analyst Ratings and Price Targets | OTC:MLPH | Benzinga
Molecular Pharmacology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Molecular Pharmacology Corp from these most-recent analyst ratings.
Analyst Ratings for Molecular Pharmacology
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Molecular Pharmacology (MLPH) stock?
There is no price target for Molecular Pharmacology
What is the most recent analyst rating for Molecular Pharmacology (MLPH)?
There is no analyst for Molecular Pharmacology
When was the last upgrade for Molecular Pharmacology (MLPH)?
There is no last upgrade for Molecular Pharmacology
When was the last downgrade for Molecular Pharmacology (MLPH)?
There is no last downgrade for Molecular Pharmacology.
When is the next analyst rating going to be posted or updated for Molecular Pharmacology (MLPH)?
There is no next analyst rating for Molecular Pharmacology.
Is the Analyst Rating Molecular Pharmacology (MLPH) correct?
There is no next analyst rating for Molecular Pharmacology.
Browse analyst ratings and price targets on all stocks.
